Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2020) 205 (12): 3235–3236.

BRIEF REVIEWS

J Immunol (2020) 205 (12): 3237–3245.

AUTOIMMUNITY

J Immunol (2020) 205 (12): 3247–3262.

  • Fgl2 is a soluble effector molecule highly expressed by TFR cells.

  • Fgl2 directly binds to B cells and TFH cells, regulating humoral responses.

  • Fgl2-deficient mice spontaneously develop an inflammatory, lupus-like autoimmunity.

J Immunol (2020) 205 (12): 3263–3276.

  • Unlike autoimmune arthritis, insulitis and T1D develop without SAP.

  • B cell Ag presentation can drive SAP-deficient T cell proliferation.

  • SAP−/− NOD mice show intact IFN-γ responses and TFH1 cell pancreatic infiltration.

J Immunol (2020) 205 (12): 3277–3290.

  • A panel of inhibitors was screened for SFs of RA patients.

  • Inhibitors for PDGFR, PI3K, and GSK-3 suppressed invasion of SFs from RA patients.

  • The inhibitors also suppressed migration, proliferation, and IL-6 production from SFs.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2020) 205 (12): 3291–3299.

  • There is currently no clinical tool to measure the immune reserve in patients.

  • A two-step, cell-based assay is sensitive and specific for over-immunosuppression.

IMMUNE REGULATION

J Immunol (2020) 205 (12): 3300–3310.

  • Colchicine induces a neutrophil contractile response in a GEF-H1–dependent manner.

  • Colchicine induces GEF-H1–dependent inhibition of neutrophil rolling and adhesion.

  • GEF-H1 is required for colchicine inhibition of neutrophil response to MSU in vivo.

J Immunol (2020) 205 (12): 3311–3318.

  • Inducible and constitutive enhancers cooperate to generate transcriptional outputs.

  • Identification of TF binding site clusters is critical in Il13 gene transcription.

IMMUNOGENETICS

J Immunol (2020) 205 (12): 3319–3332.

  • Rhesus FcγR2A allotypes differ in their interactions with different IgG subclasses.

  • Rhesus FcγR3A allotypes show little variation in IgG subclass interactions.

  • Human and macaque IgG1 but not IgG2–4 exhibit similar IgG–FcγR interactions.

IMMUNOTHERAPY AND VACCINES

J Immunol (2020) 205 (12): 3333–3347.

  • Neutrophils play critical roles in Leishmania vaccine–induced protective immunity.

  • Depletion of neutrophils impairs Leishmania vaccine efficacy.

J Immunol (2020) 205 (12): 3348–3357.

  • DR3 levels are associated with spontaneous in vivo control of HIV.

  • Upon treatment, TL1A is associated with Tregs and sDR3 with effector CD8 T cells.

  • DR3 agonists can be used to boost HIV-specific T cell responses in vitro.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2020) 205 (12): 3358–3371.

  • Agonism of CD28 improves sepsis mortality in memory but not naive hosts.

  • CD28 agonism results in enhanced production of IL-10 from Foxp3+ Treg cells in memory mice.

  • IL-10 is required for the survival benefit of CD28 agonism in septic memory mice.

J Immunol (2020) 205 (12): 3372–3382.

  • Perforin is a dominant control mechanism of B lymphoma in γHV infection.

  • Immune effector hierarchies differ in control of B lymphoma and γHV replication.

  • CD4 T cell help is not essential to control B lymphoma in γHV immune mice.

J Immunol (2020) 205 (12): 3383–3389.

  • Cells show immunological learning to prior exposure to Borrelia burgdorferi.

  • Learned responses differ by cell type and include both training and tolerance.

  • Learned responses correlate with infectious symptoms observed in murine models.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2020) 205 (12): 3390–3399.

  • The role of Mincle overexpression in bacterial pneumonia is currently unsettled.

  • Mincle overexpression rendered mice more susceptible to pneumococcal pneumonia.

  • Mincle receptor expression must be inducible in response to microbial challenge.

J Immunol (2020) 205 (12): 3400–3407.

  • Human IgG subclasses elicit distinct cytokine profiles by myeloid immune cells.

  • Subclass-specific effects are mediated by distinct metabolic reprogramming by FcγRs.

  • IgG subclasses provide pathogen- and cell type–specific immunity.

J Immunol (2020) 205 (12): 3408–3418.

  • NSUN5 effectively restricted RNA virus infection in vitro and in vivo.

  • NSUN5 acted as a novel RIG-I coreceptor.

  • NSUN5 synergized the recognition of RNA virus by RIG-I.

J Immunol (2020) 205 (12): 3419–3428.

  • Tupaia OASL1 is critical for RNA virus–induced antiviral signaling transduction.

  • tOASL1 is associated with mitochondria.

  • tOASL1 is a positive regulator of type I IFN induction by recruiting tMDA5 to tMAVS.

J Immunol (2020) 205 (12): 3429–3442.

  • A rare subset of FcRγ NK cells is highly expanded in chronic HIV-1 infection.

  • IL-18Rα impairment renders FcRγ NK cells deficient in helper cell differentiation.

  • Deficits in IFN-γ due to FcRγ NK cell expansions lead to inferior NK–DC cross-talk.

J Immunol (2020) 205 (12): 3443–3455.

  • OnMBL was able to bind and agglutinate with pathogens.

  • OnMBL was able to significantly reduce the proliferation of pathogens.

  • OnMBL could promote phagocytosis of macrophages with OnCRT interaction.

MOLECULAR AND STRUCTURAL IMMUNOLOGY

J Immunol (2020) 205 (12): 3456–3467.

  • Deletion of Gly236 in human IgG1, naturally lacking in IgG2, silences FcγR.

  • Deletion of Gly236 has no effect on complement-mediated effector functions.

  • Data suggest how IgG2 may have lost FcγRI binding during evolution.

SYSTEMS IMMUNOLOGY

J Immunol (2020) 205 (12): 3468–3479.

  • SHM targeting for a DNA 5-mer motif can differ by position.

  • Direction of differential targeting conserved across subjects and alleles.

  • Differential targeting correlates with mutability of wider neighborhood of motifs.

TRANSPLANTATION

J Immunol (2020) 205 (12): 3480–3490.

  • Kras deficiency subtly changes TCR- and IL-6–induced gene expression.

  • Deletion of Kras in donor T cells dramatically reduces aGVHD but maintains graft-versus-leukemia.

NOVEL IMMUNOLOGICAL METHODS

J Immunol (2020) 205 (12): 3491–3499.

  • We developed a sensitive total Ab bridging assay to detect SARS-CoV-2 Abs.

  • The assay reliably detects SARS-CoV-2 Abs also in nonhospitalized patients.

  • Fewer Abs arise but with similar kinetics compared with hospitalized patients.

Close Modal

or Create an Account

Close Modal
Close Modal